SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001213900-21-067654
Filing Date
2021-12-28
Accepted
2021-12-28 09:46:24
Documents
3

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea153046-8k425_aditxtinc.htm 425 69882
2 SHARE EXCHANGE AGREEMENT DATED AS OF DECEMBER 28, 2021 BY AND BETWEEN AIPHARMA G ea153046ex2-1_aditxtinc.htm EX-2.1 462967
3 PRESS RELEASE, DATED DECEMBER 28, 2021 ea153046ex99-1_aditxtinc.htm EX-99.1 27929
  Complete submission text file 0001213900-21-067654.txt   562689
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filed by) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Subject) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-39336 | Film No.: 211522358
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences